Oct 18, 2017   SOURCE: PR NewsWire

Global Drug Delivery Technologies Market to 2025 - Market is Expected to Reach USD 297.35 Bn

DUBLIN, October 18, 2017 /PRNewswire/ --

The "Global Drug Delivery Technologies Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 - 2025" report has been added to Research and Markets' offering.

http://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

The drug delivery technologies market was valued at USD 200.2 Bn in 2017, and is expected to reach USD 297.35 Bn by 2025, expanding at a CAGR of 6.9% from 2017 - 2025.

Patent expiry of several major drugs, coupled with the expensive business of development of new chemical entity has posed as a prime concern for pharmaceutical manufacturers. Development of new chemical entity is often observed to be a more expensive affair than development of novel delivery technology. Hence, several pharmaceutical manufacturers have adopted new drug delivery technologies for their portfolio as an effective life cycle management strategy.

Newer technologies through products such as orodispersible tablets, transdermal patches, pen injectors, powder inhalers and buccal tablets are among the most widely adopted products. Additionally, the demand for drug eluting implants is also on a continuous rise in the developed markets. Implantable drug delivery devices find application in diabetes management, contraception, cardiology, pain management, pain management and others.

Geographically, North America is the largest regional market for drug delivery technologies. Well structured reimbursement policies, large scale adoption of latest technologies, high prevalence of chronic diseases and high level of awareness among both care givers and patients are the prime contributors to the growth of North America drug delivery technologies market. In terms of growth rate, Asia-Pacific and Latin America are the fastest developing markets for drug delivery technologies. Fast developing healthcare infrastructure, gradually rising awareness and improving healthcare expenditure supplement the growth of emerging markets.

Intense competition among drug manufacturers to manage product life cycles of blockbuster drugs, and rising trend of manufacturing outsourcing have made the drug delivery technologies market fragmented. Merck, 3M Company, Johnson and Johnson, Becton Diskinson and Company and others are some of the major players in the global drug delivery technologies market.

Key Topics Covered:

Chapter 1 Preface

Chapter 2 Executive Summary

Chapter 3 Global Drug Delivery Technologies Market: Market Dynamics and Outlook

Chapter 4 Global Drug Delivery Technologies Market Analysis, by Mode of Administration

Chapter 5 Drug Delivery Technologies Market, by Geography

Chapter 6 Company Profiles

    --  Bayer AG
    --  Becton, Dickinson and Company
    --  3M Company
    --  Antares Pharma, Inc.
    --  Johnson & Johnson
    --  Novartis AG
    --  Pfizer, Inc.
    --  Hoffmann La-Roche
    --  Sanofi

For more information about this report visit https://www.researchandmarkets.com/research/j3txpk/global_drug

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/global-drug-delivery-technologies-market-to-2025---market-is-expected-to-reach-usd-29735-bn-300538771.html

SOURCE Research and Markets